Lorenzo Buroni

Royal Marsden NHS Foundation Trust — United Kingdom

Medicine · Health Sciences

8h-index632citations124works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(46), Cancer, Lipids, and Metabolism(44), Immunotherapy and Immune Responses(21), RNA Interference and Gene Delivery(20), Eicosanoids and Hypertension Pharmacology(17)

Publications124 total

Developing therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer
iScience·2025Open Access
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer
Nature Communications·2025· 2 citedOpen Access
BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress
Nature Communications·2025· 8 citedOpen Access
Figure 6 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S8 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Data from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Figure 4 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Figure 5 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Figure 1 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S1 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Figure 2 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S4 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S2 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Figure 3 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S10 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S5 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S3 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Tables S1-S13 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S9 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S7 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
page 1 of 7Next →

Frequent Co-authors

Johann S. de Bono(50), Antje Neeb(48), Bora Gürel(46), Adam Sharp(46), Suzanne Carreira(46), Susana Miranda(45), Ruth Riisnaes(45), Mateus Crespo(44), Jan Rekowski(33), Jonathan Welti(30), Amanda Swain(29), Denisa Bogdan(27), Juan M. Jiménez‐Vacas(26), Veronica Gil(25), Jian Ning(23), Ines Figueiredo(23), Ana Ferreira(23), Ines Figueiredo(23), Wei Yuan(23), Christina Guo(21)